메뉴 건너뛰기




Volumn 13, Issue 2, 2013, Pages 157-167

Effects of bevacizumab in retina and choroid after intravitreal injection into monkey eyes

Author keywords

bevacizumab; choroidal vessels; electron microscopy; immunohistochemistry; monkey; retinal vessels; thrombocytes

Indexed keywords

BEVACIZUMAB; GLIAL FIBRILLARY ACIDIC PROTEIN; IODINE 125; PHOSPHATE BUFFERED SALINE;

EID: 84872187217     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2012.748741     Document Type: Article
Times cited : (24)

References (45)
  • 1
    • 20544455330 scopus 로고    scopus 로고
    • Bevacizumab (avastin), a humanized anti-vegf monoclonal antibody for cancer therapy
    • Ferrara N, Hillan KJ, Novotny W. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy. Biochem Biophys Res Commun 2005;333:328-34
    • (2005) Biochem Biophys Res Commun , vol.333 , pp. 328-34
    • Ferrara, N.1    Hillan, K.J.2    Novotny, W.3
  • 3
    • 43249114808 scopus 로고    scopus 로고
    • A new weapon for attacking tumor blood vessels
    • Semenza GL. A new weapon for attacking tumor blood vessels. N Engl J Med 2008;358:2066-7
    • (2008) N Engl J Med , vol.358 , pp. 2066-7
    • Semenza, G.L.1
  • 4
    • 23044505200 scopus 로고    scopus 로고
    • Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration
    • Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:331-4
    • (2005) Ophthalmic Surg Lasers Imaging , vol.36 , pp. 331-4
    • Rosenfeld, P.J.1    Moshfeghi, A.A.2    Puliafito, C.A.3
  • 5
    • 65349108729 scopus 로고    scopus 로고
    • Bevacizumab (avastin) for the treatment of ocular disease
    • Gunther JB, Altaweel MM. Bevacizumab (Avastin) for the treatment of ocular disease. Surv Ophthalmol 2009;54:372-400
    • (2009) Surv Ophthalmol , vol.54 , pp. 372-400
    • Gunther, J.B.1    Altaweel, M.M.2
  • 7
    • 38149028284 scopus 로고    scopus 로고
    • Reversible posterior leukoencephalopathy syndrome in cancer
    • Vaughn C, Zhang L, Schiff D. Reversible posterior leukoencephalopathy syndrome in cancer. Curr Oncol Rep 2008;10:86-91
    • (2008) Curr Oncol Rep , vol.10 , pp. 86-91
    • Vaughn, C.1    Zhang, L.2    Schiff, D.3
  • 8
    • 34247231012 scopus 로고    scopus 로고
    • The proportion of patients with metastatic non-small cell lung cancer potentially eligible for treatment with bevacizumab: A single institutional survey
    • PII 0124389420060600000023
    • Velcheti V, Viswanathan A, Govindan R. The proportion of patients with metastatic non-small cell lung cancer potentially eligible for treatment with bevacizumab: a single institutional survey. J Thorac Oncol 2006;1:501 (Pubitemid 47181431)
    • (2006) Journal of Thoracic Oncology , vol.1 , Issue.5 , pp. 501
    • Velcheti, V.1    Viswanathan, A.2    Govindan, R.3
  • 11
    • 34248598513 scopus 로고    scopus 로고
    • Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab
    • This study shows activation of thrombocytes after intravitreal injection of bevacizumab into monkey eyes
    • Peters S, Heiduschka P, Julien S, et al. Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab. Am J Ophthalmol 2007;143:995-1002 This study shows activation of thrombocytes after intravitreal injection of bevacizumab into monkey eyes.
    • (2007) Am J Ophthalmol , vol.143 , pp. 995-1002
    • Peters, S.1    Heiduschka, P.2    Julien, S.3
  • 12
    • 57749207937 scopus 로고    scopus 로고
    • Bevacizumab immune complexes activate platelets and induce thrombosis in fcgr2a transgenic mice
    • This is a key paper in the field. It provides a mechanism for thrombotic events observed in bevacizumab therapy
    • Meyer T, Robles-Carrillo L, Robson T, et al. Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice. J Thromb Haemost 2009;7:171-81 .This is a key paper in the field. It provides a mechanism for thrombotic events observed in bevacizumab therapy.
    • (2009) J Thromb Haemost , vol.7 , pp. 171-81
    • Meyer, T.1    Robles-Carrillo, L.2    Robson, T.3
  • 13
    • 79956218863 scopus 로고    scopus 로고
    • Ranibizumab and bevacizumab for neovascular age-related macular degeneration
    • Martin DF, Maguire MG, Ying GS, et al. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011;364:1897-908
    • (2011) N Engl J Med , vol.364 , pp. 908
    • Martin, D.F.1    Maguire, M.G.2    Ying, G.S.3
  • 14
    • 79951560449 scopus 로고    scopus 로고
    • Arterial thromboembolic events in patients with exudative age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab
    • In this retrospective study, bevacizumab raised the risk of arterial thromboembolic events when compared to ranibizumab
    • Carneiro AM, Barthelmes D, Falcao MS, et al. Arterial thromboembolic events in patients with exudative age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab. Ophthalmologica 2011;225:211-21 . In this retrospective study, bevacizumab raised the risk of arterial thromboembolic events when compared to ranibizumab.
    • (2011) Ophthalmologica , vol.225 , pp. 211-21
    • Carneiro, A.M.1    Barthelmes, D.2    Falcao, M.S.3
  • 15
    • 80051865307 scopus 로고    scopus 로고
    • Emerging evidence concerning systemic safety of anti-vegf agents-should ophthalmologists be concerned?
    • Lim LS, Cheung CM, Mitchell P, et al. Emerging evidence concerning systemic safety of anti-VEGF agents-should ophthalmologists be concerned? Am J Ophthalmol 2011;152:329-31
    • (2011) Am J Ophthalmol , vol.152 , pp. 329-31
    • Lim, L.S.1    Cheung, C.M.2    Mitchell, P.3
  • 16
    • 79958228219 scopus 로고    scopus 로고
    • Characterization and allelic polymorphisms of rhesus macaque (macaca mulatta) igg fc receptor genes
    • Nguyen DC, Scinicariello F, Attanasio R. Characterization and allelic polymorphisms of rhesus macaque (Macaca mulatta) IgG Fc receptor genes. Immunogenetics 2011;63:351-62
    • (2011) Immunogenetics , vol.63 , pp. 351-62
    • Nguyen, D.C.1    Scinicariello, F.2    Attanasio, R.3
  • 17
    • 84866558151 scopus 로고    scopus 로고
    • Formation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eye
    • This study shows reduction of choriocapillaris after intravitreal injection of bevacizumab into monkey eyes.
    • Schraermeyer U, Julien S. Formation of immune complexes and thrombotic microangiopathy after intravitreal injection of bevacizumab in the primate eye. Graefes Arch Clin Exp Ophthalmol 2012;250:1303-1 .. This study shows reduction of choriocapillaris after intravitreal injection of bevacizumab into monkey eyes.
    • (2012) Graefes Arch Clin Exp Ophthalmol , vol.250 , pp. 1303-1
    • Schraermeyer, U.1    Julien, S.2
  • 18
    • 34547383713 scopus 로고
    • Preparation of iodine-131 labelled human growth hormone of high specific activity
    • Hunter WM, Greenwood FC. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962;194:495-6
    • (1962) Nature , vol.194 , pp. 495-6
    • Hunter, W.M.1    Greenwood, F.C.2
  • 19
    • 0013786550 scopus 로고
    • The identification of platelets and platelet antigens in histological sections
    • Carstairs KC. The identification of platelets and platelet antigens in histological sections. J Pathol Bacteriol 1965;90:225-31
    • (1965) J Pathol Bacteriol , vol.90 , pp. 225-31
    • Carstairs, K.C.1
  • 21
    • 77649253359 scopus 로고    scopus 로고
    • Fcrn receptor-mediated pharmacokinetics of therapeutic igg in the eye
    • Kim H, Robinson SB, Csaky KG. FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye. Mol Vis 2009;15:2803-12
    • (2009) Mol Vis , vol.15 , pp. 2803-12
    • Kim, H.1    Robinson, S.B.2    Csaky, K.G.3
  • 23
    • 0027515012 scopus 로고
    • Detection and quantification of secreted soluble fc gamma riia in human sera by an enzyme-linked immunosorbent assay
    • Astier A, de la Salle H, Moncuit J, et al. Detection and quantification of secreted soluble Fc gamma RIIA in human sera by an enzyme-linked immunosorbent assay. J Immunol Methods 1993;166:1-10
    • (1993) J Immunol Methods , vol.166 , pp. 1-10
    • Astier, A.1    De La Salle, H.2    Moncuit, J.3
  • 25
    • 2442621619 scopus 로고    scopus 로고
    • Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
    • Ferrara N, Hillan KJ, Gerber HP, et al. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 2004;3:391-400 (Pubitemid 38618122)
    • (2004) Nature Reviews Drug Discovery , vol.3 , Issue.5 , pp. 391-400
    • Ferrara, N.1    Hillan, K.J.2    Gerber, H.-P.3    Novotny, W.4
  • 26
    • 79958045498 scopus 로고    scopus 로고
    • Dynamics of a heparin-binding domain of vegf(165) complexed with its inhibitor triamterene
    • Jeong KW, Lee JY, Lee SA, et al. Dynamics of a heparin-binding domain of VEGF(165) complexed with its inhibitor triamterene. Biochemistry 2011;50:4843-54
    • (2011) Biochemistry , vol.50 , pp. 4843-54
    • Jeong, K.W.1    Lee, J.Y.2    Lee, S.A.3
  • 27
    • 84863075395 scopus 로고    scopus 로고
    • Binding affinities of vascular endothelial growth factor (vegf) for heparin-derived oligosaccharides
    • Zhao W, McCallum SA, Xiao Z, et al. Binding affinities of vascular endothelial growth factor (VEGF) for heparin-derived oligosaccharides. Biosci Rep 2012;32:71-81
    • (2012) Biosci Rep , vol.32 , pp. 71-81
    • Zhao, W.1    McCallum, S.A.2    Xiao, Z.3
  • 28
    • 0025101122 scopus 로고
    • A view of the human idiotypic repertoire. Electron microscopic and immunologic analyses of spontaneous idiotype-Anti-idiotype dimers in pooled human igg
    • Roux KH, Tankersley DL. A view of the human idiotypic repertoire. Electron microscopic and immunologic analyses of spontaneous idiotype-Anti-idiotype dimers in pooled human IgG. J Immunol 1990;144:1387-94
    • (1990) J Immunol , vol.144 , pp. 1387-94
    • Roux, K.H.1    Tankersley, D.L.2
  • 29
    • 77953944193 scopus 로고    scopus 로고
    • Interactions with heparin-like molecules during erythrocyte invasion by plasmodium falciparum merozoites
    • Boyle MJ, Richards JS, Gilson PR, et al. Interactions with heparin-like molecules during erythrocyte invasion by Plasmodium falciparum merozoites. Blood 2010;115:4559-68
    • (2010) Blood , vol.115 , pp. 4559-68
    • Boyle, M.J.1    Richards, J.S.2    Gilson, P.R.3
  • 30
    • 0036025336 scopus 로고    scopus 로고
    • Fcγ receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro
    • DOI 10.1046/j.1365-2249.2002.01972.x
    • Tebo AE, Kremsner PG, Luty AJ. Fcgamma receptor-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes in vitro. Clin Exp Immunol 2002;130:300-6 (Pubitemid 35286218)
    • (2002) Clinical and Experimental Immunology , vol.130 , Issue.2 , pp. 300-306
    • Tebo, A.E.1    Kremsner, P.G.2    Luty, A.J.F.3
  • 31
    • 0037443518 scopus 로고    scopus 로고
    • Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1α domain of PfEMP1
    • DOI 10.1182/blood-2002-07-2016
    • Vogt AM, Barragan A, Chen Q, et al. Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1. Blood 2003;101:2405-11 (Pubitemid 36302089)
    • (2003) Blood , vol.101 , Issue.6 , pp. 2405-2411
    • Vogt, A.M.1    Barragan, A.2    Chen, Q.3    Kironde, F.4    Spillmann, D.5    Wahlgren, M.6
  • 32
    • 4344631854 scopus 로고    scopus 로고
    • Heparan sulphate identified on human erythrocytes: A Plasmodium falciparum receptor
    • DOI 10.1042/BJ20040762
    • Vogt AM, Winter G, Wahlgren M, et al. Heparan sulphate identified on human erythrocytes: a Plasmodium falciparum receptor. Biochem J 2004;381:593-7 (Pubitemid 39120467)
    • (2004) Biochemical Journal , vol.381 , Issue.3 , pp. 593-597
    • Vogt, A.M.1    Winter, G.2    Wahlgren, M.3    Spillmann, D.4
  • 33
    • 0028171143 scopus 로고
    • Role of neutrophil FcγRIIa (CD32) and FcγRIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes
    • Bredius RG, Fijen CA, De Haas M, et al. Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- And IgG3-opsonized bacteria and erythrocytes. Immunology 1994;83:624-30 (Pubitemid 24374097)
    • (1994) Immunology , vol.83 , Issue.4 , pp. 624-630
    • Bredius, R.G.M.1    Fijen, C.A.P.2    De Haas, M.3    Kuijper, E.J.4    Weening, R.S.5    Van De Winkel, J.G.J.6    Out, T.A.7
  • 35
    • 77649227816 scopus 로고    scopus 로고
    • Retinal artery occlusion following intravitreal anti-vegf therapy
    • von Hanno T, Kinge B, Fossen K. Retinal artery occlusion following intravitreal anti-VEGF therapy. Acta Ophthalmol 2010;88:263-6
    • (2010) Acta Ophthalmol , vol.88 , pp. 263-6
    • Von Hanno, T.1    Kinge, B.2    Fossen, K.3
  • 36
    • 84864385517 scopus 로고    scopus 로고
    • Lipofuscin can be eliminated from the retinal pigment epithelium of monkeys
    • Julien S, Schraermeyer U. Lipofuscin can be eliminated from the retinal pigment epithelium of monkeys. Neurobiol Aging 2012;33:2390-7
    • (2012) Neurobiol Aging , vol.33 , pp. 2390-7
    • Julien, S.1    Schraermeyer, U.2
  • 37
    • 84856369109 scopus 로고    scopus 로고
    • The effect of intravitreal injection of bevacizumab on retinal circulation in patients with neovascular macular degeneration
    • This prospective study assesses the long-term effect of intravitreal bevacizumab on vascular tone and on retinal blood flow including the neuroretinal rim in AMD patients
    • Fontaine O, Olivier S, Descovich D, et al. The effect of intravitreal injection of bevacizumab on retinal circulation in patients with neovascular macular degeneration. Invest Ophthalmol Vis Sci 2011;52:7400-4 .. This prospective study assesses the long-term effect of intravitreal bevacizumab on vascular tone and on retinal blood flow including the neuroretinal rim in AMD patients.
    • (2011) Invest Ophthalmol Vis Sci , vol.52 , pp. 7400-4
    • Fontaine, O.1    Olivier, S.2    Descovich, D.3
  • 38
    • 84863316257 scopus 로고    scopus 로고
    • The effect of intravitreal bevacizumab (avastin) injection on retinal blood flow velocity in patients with choroidal neovascularization
    • This paper describes using an elegant technique early arterial and venous velocity changes after intravitreal bevacizumab
    • Barak A, Burgansky-Eliash Z, Barash H, et al. The effect of intravitreal bevacizumab (Avastin) injection on retinal blood flow velocity in patients with choroidal neovascularization. Eur J Ophthalmol 2012;22:423-30 This paper describes using an elegant technique early arterial and venous velocity changes after intravitreal bevacizumab.
    • (2012) Eur J Ophthalmol , vol.22 , pp. 423-30
    • Barak, A.1    Burgansky-Eliash, Z.2    Barash, H.3
  • 39
    • 84860839218 scopus 로고    scopus 로고
    • Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration
    • Hosseini H, Lotfi M, Esfahani MH, et al. Effect of intravitreal bevacizumab on retrobulbar blood flow in injected and uninjected fellow eyes of patients with neovascular age-related macular degeneration. Retina 2012;32:967-71
    • (2012) Retina , vol.32 , pp. 967-71
    • Hosseini, H.1    Lotfi, M.2    Esfahani, M.H.3
  • 40
    • 69049088006 scopus 로고    scopus 로고
    • The effect of intravitreal bevacizumab (avastin) administration on systemic hypertension
    • The findings of this study show that there is a risk of dysregulation of blood pressure levels or persistence of hypertension in hypertensive patients after intravitreal bevacizumab injections
    • Rasier R, Artunay O, Yuzbasioglu E, et al. The effect of intravitreal bevacizumab (avastin) administration on systemic hypertension. Eye (Lond) 2009;23:1714-18 The findings of this study show that there is a risk of dysregulation of blood pressure levels or persistence of hypertension in hypertensive patients after intravitreal bevacizumab injections
    • (2009) Eye (Lond) , vol.23 , pp. 1714-18
    • Rasier, R.1    Artunay, O.2    Yuzbasioglu, E.3
  • 41
    • 0024322659 scopus 로고
    • Platelet ultrastructure and secretion in acute ischemic stroke
    • Joseph R, Riddle JM, Welch KM, et al. Platelet ultrastructure and secretion in acute ischemic stroke. Stroke 1989;20:1316-19 (Pubitemid 19254544)
    • (1989) Stroke , vol.20 , Issue.10 , pp. 1316-1319
    • Joseph, R.1    Riddle, J.M.2    Welch, K.M.A.3    D'Andrea, G.4
  • 42
    • 54249138238 scopus 로고    scopus 로고
    • Electron opaque structures in human platelets: Which are or are not dense bodies?
    • White JG. Electron opaque structures in human platelets: which are or are not dense bodies? Platelets 2008;19:455-66
    • (2008) Platelets , vol.19 , pp. 455-66
    • White, J.G.1
  • 43
    • 79959458021 scopus 로고    scopus 로고
    • Intravitreal anti-vegf therapy for neovascular age-related macular degeneration and the risk of stroke
    • Cleary CA, Sharaznayan D, Hickey-Dwyer M. Intravitreal anti-VEGF therapy for neovascular age-related macular degeneration and the risk of stroke. Ir Med J 2011;104:146-9
    • (2011) Ir Med J , vol.104 , pp. 146-9
    • Cleary, C.A.1    Sharaznayan, D.2    Hickey-Dwyer, M.3
  • 44
    • 84864569800 scopus 로고    scopus 로고
    • A safety review and meta-Analyses of bevacizumab and ranibizumab: Off-label versus goldstandard
    • Schmucker C, Ehlken C, Agostini HT, et al. A Safety Review and Meta-Analyses of Bevacizumab and Ranibizumab: off-Label versus Goldstandard. PLoS ONE 2012;7:e42701
    • (2012) PLoS ONE , vol.7
    • Schmucker, C.1    Ehlken, C.2    Agostini, H.T.3
  • 45
    • 70349567396 scopus 로고    scopus 로고
    • Effect of intravitreal injection of high-dose bevacizumab in monkey eyes
    • Sakurai K, Akiyama H, Shimoda Y, et al. Effect of intravitreal injection of high-dose bevacizumab in monkey eyes. Invest Ophthalmol Vis Sci 2009;50:4905-16
    • (2009) Invest Ophthalmol Vis Sci , vol.50 , pp. 4905-16
    • Sakurai, K.1    Akiyama, H.2    Shimoda, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.